Dr Edward Wild MA MB BChir FRCP PhD

Highlighted publication

Byrne et al, Lancet Neurology 2017

Neurofilament Light Protein in Blood as a Potential Biomarker of Neurodegeneration in Huntington’s Disease: A Retrospective Cohort Analysis

In this Lancet Neurology paper, we report neurofilament light chain as the first blood biomarker to predict onset, progression and neurodegeneration in Huntington’s disease.

Highlighted media

BBC NewsHuntington’s disease trial test is ‘major advance’

Daily TelegraphSimple blood test holds out hope for Huntington’s disease breakthrough


I’m a Consultant Neurologist at the National Hospital for Neurology and Neurosurgery in London’s Queen Square. I run clinics in general neurology, neurogenetic movement disorders and Huntington’s disease.

I’m an MRC Clinician Scientist at UCL Institute of Neurology, and a Principal Investigator at UCL Huntington’s Disease Centre. My clinical research aims to accelerate the development of new therapies to make a real difference for people impacted by Huntington’s disease.

I studied medicine at Christ’s College, Cambridge University, and have worked in neurology since 2005. My PhD research at UCL Institute of Neurology won the 2009 Queen Square Prize in Neurology.

I believe that scientists have a duty to make their work accessible and understandable to the people who need it most. In 2010, I co-founded HDBuzz, an online source of reliable, impartial, easy-to-understand information about HD research. HDBuzz is now the world’s foremost HD research news source. In recognition of this, I was awarded the 2012 Michael Wright Community Leadership Award by the Huntington Society of Canada and the 2014 Research Award by the Huntington’s Disease Society of America.

I have authored 7 book chapters and over 70 peer-reviewed publications. I serve on the medical advisory panel of the Huntington’s Disease Association, the Editorial Boards of Journal of Huntington’s Disease and PLoS Currents: Huntington’s Disease and the steering committee to the UK All-Party Parliamentary Group on Huntington’s disease. I am the Lead Facilitator of the European Huntington’s Disease Network‘s Biomarkers Working Group and an emeritus member of the Network’s Scientific and Bioethical Advisory Committee.
Queen Square Neurologist